Bruce Power and Kinectrics have entered into a Memorandum of Understanding to collaborate in the production of medical isotopes.
Bruce Power is a significant global supplier of Cobalt-60, a medical isotope used to sterilize medical equipment in hospitals around the world, to treat brain tumours, and to assist in the fight against cancer.
Kinectrics will base its future development activities for isotope services out of its Etobicoke headquarters, and utilize satellite facilities it has established in Bruce County.
This will build on an existing expertise the company has, and further supports ongoing operations at Bruce Power, as well as its Life-Extension Program.
"We are proud to be a strategic partner of Bruce Power to help meet this critical global need for these innovative products," said David Harris, president and CEO at Kinectrics. "By establishing an Ontario-based hub of research and innovation in Etobicoke and Bruce County, we are very excited to be involved in supporting the nuclear sector’s role in health care, and developing more targeted and effective cancer treatments."
Bruce Power's President and CEO Mike Rencheck added, "The collaboration with Kinectrics will build on our development of Ontario’s Nuclear Innovation Institute and use our collective expertise and industry knowledge to meet the global demand for nuclear isotopes while establishing a centre of excellence in Bruce County."
Both companies are members of the recently established Canadian Nuclear Isotope Council, which advocates for Canada’s continued role in the production of the world’s supply of life-saving radioisotopes.